Short answer
Strata Critical Medical, Inc. (SRTA) filed an 8-K current report with the SEC on June 3, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected William A. Heyburn and Andrew Lauck as Class II directors through the 2029 annual meeting.
Strata Critical Medical, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected William A. Heyburn and Andrew Lauck as Class II directors through the 2029 annual meeting
- Heyburn received 46,050,902 votes for, while Lauck received 39,525,159, indicating materially stronger support for Heyburn
- Deloitte & Touche LLP ratified as independent auditor for fiscal 2026, with 58,946,832 votes for
- Executive compensation approved on an advisory basis, with 38,497,962 votes for versus 8,022,682 against
- 12,687,496 broker non-votes on director and say-on-pay proposals, limiting interpretation of shareholder opposition
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Strata Critical Medical, Inc. 8-K filings
Get the next SRTA 8-K as it lands
Follow SRTA for push alerts, or ask the research agent what this filing means.